{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:00:58Z","timestamp":1778367658391,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1053\/j.jvca.2025.01.042","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:50:04Z","timestamp":1738371004000},"page":"1250-1256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of Angiotensin II in Patients With Catecholamine-Resistant Vasodilatory Shock Requiring Continuous Renal Replacement Therapy (ANGEL CRRT)"],"prefix":"10.1053","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8075-7342","authenticated-orcid":false,"given":"Meaghan A.","family":"Rettele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-7049","authenticated-orcid":false,"given":"Adham M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Welge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby S.","family":"Shemanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shais S.","family":"Jallu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron J.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majdi S.","family":"Hamarshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Kozinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2025.01.042_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.042_bib0002","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1053\/j.jvca.2025.01.042_bib0003","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0266462320000082","article-title":"Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis","volume":"36","author":"Busse","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1053\/j.jvca.2025.01.042_bib0006","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0007","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0008","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000183912","article-title":"Elevated plasma renin activity associated with renal dysfunction","volume":"44","author":"Kehoe","year":"1986","journal-title":"Nephron"},{"key":"10.1053\/j.jvca.2025.01.042_bib0009","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: A multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.01.042_bib0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2025.01.042_bib0011","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0310057X0903700212","article-title":"Outcome of patients receiving high dose vasopressor therapy: A retrospective cohort study","volume":"37","author":"Jenkins","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"10.1053\/j.jvca.2025.01.042_bib0012","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1590\/S1807-59322008000400012","article-title":"The impact of duration of organ dysfunction on the outcome of patients with severe sepsis and septic shock","volume":"63","author":"Freitas","year":"2008","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1053\/j.jvca.2025.01.042_bib0013","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2025.01.042_bib0014","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: Results of a multicenter, prospective study. Working group on \"sepsis-related problems\" of the European Society of Intensive Care Medicine","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/08850666221118282","article-title":"Vasopressin response and clinical trajectory in septic shock patients","volume":"38","author":"Bauer","year":"2023","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0016","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock","volume":"50","author":"Sacha","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0017","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: An exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2025.01.042_bib0018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: Not too much, too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2025.01.042_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcrc.2020.10.023","article-title":"Predictors of dysrhythmias with norepinephrine use in septic shock","volume":"61","author":"Wieruszewski","year":"2021","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2025.01.042_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.1.5691.253","article-title":"Renin and acute renal failure: Studies in man","volume":"1","author":"Brown","year":"1970","journal-title":"Br Med J"},{"key":"10.1053\/j.jvca.2025.01.042_bib0021","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcvm.2020.00151","article-title":"Incidence of venous thromboembolism in hospitalized coronavirus disease 2019 patients: A systematic review and meta-analysis","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1053\/j.jvca.2025.01.042_bib0022","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1378\/chest.15-0287","article-title":"VTE incidence and risk factors in patients with severe sepsis and septic shock","volume":"148","author":"Kaplan","year":"2015","journal-title":"Chest"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702500103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105307702500103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:39:35Z","timestamp":1744400375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105307702500103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S105307702500103X"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2025.01.042","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Angiotensin II in Patients With Catecholamine-Resistant Vasodilatory Shock Requiring Continuous Renal Replacement Therapy (ANGEL CRRT)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2025.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}